| Name | Title | Contact Details |
|---|---|---|
Eduardo Menchaca |
Chief Compliance Officer | Profile |
Julie Lewis |
General Counsel and Corporate Secretary | Profile |
Omega Medical Laboratories is a Reading, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MEDHOST is a provider of market-leading enterprise, departmental and healthcare engagement solutions to more than 1,100 healthcare facilities. Our integrated product portfolio includes intuitive, cloud-based solutions, including YourCareEverywhere, a robust health and wellness consumer engagement platform. Our broad offering of hosting, outsourcing, marketing and consulting services are changing how clinicians and hospital leaders work and collaborate, while generating notable operational improvements. MEDHOST delivers value by enabling hospitals of all types and all sizes to better manage the business of healthcare across the care continuum while meeting evolving regulatory requirements.
Specialty Surgical Instrmnttn is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone`s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone`s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.
Lombard Medical Technologies (LMT) develops, manufactures and markets stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The Company was established in July 2000 and currently employs over 100 people at Didcot, Sheffield and Ayrshire in the UK and in the USA. The Company also has trade investments in an emerging medical device company. Lombard Medical Technologies PLC is listed on the London Stock Exchange (AIM) under the symbol LMT.